Who has invested in ValenzaBio?

Fidelity Investments, Pierre Fabre, Citadel are named among the investors backing ValenzaBio.

ValenzaBio Funding: $79M Raised, Series A (2021)

ValenzaBio funding overview

ValenzaBio is based in Bethesda. ValenzaBio has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2021. The round record for ValenzaBio runs through 2021; nothing later has been disclosed. Investors on record include Fidelity Investments, Pierre Fabre, Citadel. 3 distinct backers are named across the disclosed rounds.

ValenzaBio at a glance

Total raised: $79M
Latest round: Series A
Latest round date: April 2021
Headquarters: Bethesda
Notable investors: Fidelity Investments, Pierre Fabre, Citadel

Frequently asked about ValenzaBio funding

How much has ValenzaBio raised?: ValenzaBio has raised $79M in total disclosed funding across the rounds on record.
Who has invested in ValenzaBio?: Fidelity Investments, Pierre Fabre, Citadel are named among the investors backing ValenzaBio.
What was the latest ValenzaBio funding round?: The most recent disclosed round is a Series A, announced in April 2021.
Where is ValenzaBio based?: ValenzaBio is based in Bethesda.
When did ValenzaBio last raise?: The last disclosed ValenzaBio round closed in April 2021 at Series A.

Totals shown for ValenzaBio aggregate every disclosed round on file. To see how that compares, browse the companies in Bethesda and the investors behind them below.

ValenzaBio Funding: $79M Raised, Series A (2021)

ValenzaBio funding overview

ValenzaBio at a glance

Frequently asked about ValenzaBio funding

Companies related to ValenzaBio (29)

Browse related funding lists (4)